Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inmune Bio (INMB) Asset Utilization Ratio (2021 - 2025)

Inmune Bio's Asset Utilization Ratio history spans 5 years, with the latest figure at 0.0 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 76.35% year-over-year to 0.0; the TTM value through Sep 2025 reached 0.0, up 76.35%, while the annual FY2024 figure was 0.0, 87.02% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.0 at Inmune Bio, up from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.01 in Q3 2022 and bottomed at 0.0 in Q2 2021.
  • The 5-year median for Asset Utilization Ratio is 0.0 (2021), against an average of 0.0.
  • The largest annual shift saw Asset Utilization Ratio skyrocketed 6084.1% in 2022 before it plummeted 88.29% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then skyrocketed by 159.06% to 0.0 in 2022, then crashed by 42.67% to 0.0 in 2023, then plummeted by 88.29% to 0.0 in 2024, then surged by 364.23% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for INMB's Asset Utilization Ratio are 0.0 (Q3 2025), 0.0 (Q2 2025), and 0.0 (Q1 2025).